InsiderClue
Insiders · Profile

Whitley Richard James

Director at Dogwood Therapeutics · Director at Gilead Sciences. Filing since 1 Nov 2012. CIK 0001441661

DWTX Dogwood Therapeutics, Inc. Director · 4 trades GILD Gilead Sciences Director · 19 trades
Company
Date
Role
Action
Shares
Amount
Of holding
DWTX Dogwood Therapeutics, Inc.
8 Dec 2022
Director
Sold, plan not stated
1,800
$466.38
72.0%
DWTX Dogwood Therapeutics, Inc.
18 May 2022
Director
Bought
500
$2.26K
25.0%
DWTX Dogwood Therapeutics, Inc.
6 Jan 2022
Director
Bought
1,800
$10.30K
900%
DWTX Dogwood Therapeutics, Inc.
23 Dec 2021
Director
Bought
200
$1.15K
opened
GILD Gilead Sciences
3 May 2021
Director
Sold, plan not stated
20,282
$1.31M
39.5%
GILD Gilead Sciences
1 May 2019
Director
Sold, plan not stated
9,534
$619.93K
27.5%
GILD Gilead Sciences
1 Apr 2019
Director
Sold, plan not stated
9,534
$624.25K
27.5%
GILD Gilead Sciences
24 Nov 2015
Director
Sold, plan not stated
169
$17.99K
0.5%
GILD Gilead Sciences
23 Nov 2015
Director
Sold, plan not stated
2,863
$306.85K
8.5%
GILD Gilead Sciences
20 Nov 2015
Director
Sold, plan not stated
5,514
$589.92K
14.0%
GILD Gilead Sciences
2 Mar 2015
Director
Sold, plan not stated
5,000
$517.14K
24.2%
GILD Gilead Sciences
2 Feb 2015
Director
Sold, plan not stated
5,000
$528.36K
24.2%
GILD Gilead Sciences
2 Jan 2015
Director
Sold, plan not stated
5,000
$476.10K
24.2%
GILD Gilead Sciences
1 Dec 2014
Director
Sold, plan not stated
5,000
$500.97K
24.2%
GILD Gilead Sciences
3 Nov 2014
Director
Sold, plan not stated
5,000
$560.09K
24.2%
GILD Gilead Sciences
1 Oct 2014
Director
Sold, plan not stated
5,000
$534.95K
24.2%
GILD Gilead Sciences
2 Sep 2014
Director
Sold, plan not stated
5,000
$540.50K
24.2%
GILD Gilead Sciences
1 Aug 2014
Director
Sold, plan not stated
5,000
$455.00K
24.2%
GILD Gilead Sciences
1 Jul 2014
Director
Sold, plan not stated
5,000
$418.25K
24.2%
GILD Gilead Sciences
2 Jun 2014
Director
Sold, plan not stated
5,000
$404.75K
24.2%
GILD Gilead Sciences
1 May 2014
Director
Sold, plan not stated
5,000
$393.15K
28.1%
GILD Gilead Sciences
1 Apr 2014
Director
Sold, plan not stated
5,000
$365.45K
27.6%
GILD Gilead Sciences
1 Nov 2012
Director
Sold, plan not stated
7,226
$490.01K
66.6%
23 decisions on file.